// App-Quantinova.ai

2779 : A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome

Researchers

Presenter

  • Andrew D. Kelly

Principal Investigators

  • Heike Kroeger

  • Jumpei Yamazaki

  • Rodolphe Taby

  • Frank Neumann

  • Sijia Yu

  • Justin T. Lee

  • Rong He

  • Shoudan Liang

  • Yue Lu

  • Matteo Cesaroni

  • Sherry A. Pierce

  • Steven M. Kornblau

  • Carlos E. Bueso-Ramos

  • Farhad Ravandi

  • Hagop M. Kantarjain

  • Jaroslav Jelinek

  • Jean-Pierre J. Issa

Medical Centers

  • Temple University School of Medicine, Philadelphia, PA

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved